
One of the difficult dilemmas facing doctors treating patients with psoriasis during the COVID‐19 pandemic has been whether to continue treatments for the disease that potentially may reduce the patient’s resistance to infection. In this study from France the investigating team compared the risk (chance) of admissions to hospital and death among patients with psoriasis receiving different types of treatment for psoriasis compared with patients with psoriasis who were not receiving treatment. The medications studied included topically applied medicines (i.e. ones applied to the skin), oral medicines and biologic medicines; in both of these last groups the medications are designed to reduce some aspects of the immune response...
Like
Save
Share